Varicella vaccination among US adolescents: coverage and missed opportunities, 2007–2014

Details

• Alternative Title:
  J Public Health Manag Pract
• Personal Author:
  Leung, Jessica ; Reagan-Steiner, Sarah ; Lopez, Adriana ; Jeyarajah, Jenny ; Marin, Mona
• Description:
  Context:
  
  Since 2007, 2 doses of varicella vaccine have been routinely recommended, with a catch-up second dose recommended for those who received only 1 prior dose.
  
  Objective:
  
  To examine ≥2-dose varicella vaccination coverage and the proportions of adolescents with evidence of immunity to varicella (≥2 doses of vaccine or varicella history) during 2007–2014. To assess timing of second-dose receipt, factors associated with ≥2 dose vaccination, and missed second dose opportunities during 2014.
  
  Design, Setting and Participants:
  
  We used data from the 2007–2014 National Immunization Survey–Teen (NIS-Teen), which collects information on adolescents ages 13–17 years in the United States.
  
  Results:
  
  From 2007 to 2014, ≥2-dose varicella vaccination coverage increased from 8.3% to 66.9% in 13–15 year-olds, and from 3.6% to 56.7% in 16–17 year-olds. The proportions with evidence of immunity also increased from 68.0% to 84.1% (13–15 year-olds) and 78.6% to 83.4% (16–17 year-olds). In 2014, 13.4% of 13–15 year-olds and 3.2% of 16–17 year-olds had received their second dose at 4–6 years. Factors most significantly associated with lower ≥2-dose coverage were not having a 11–12 year well-child visit, not receiving an adolescent vaccine, and residence in a state with no 2-dose immunization school entry requirement. Seventy-seven percent of 1-dose vaccinated adolescents had ≥1 missed opportunity to receive their second dose; were they not missed, 2-dose coverage would have increased from 79.5% to 94.8%.
  
  Conclusions:
  
  Levels of ≥2-dose varicella vaccination coverage and the proportion of adolescents with evidence of immunity increased from 2007 to 2014, though 16% lacked evidence of immunity in 2014. Though catch-up campaigns have succeeded, missed vaccination opportunities persist.
  
  
• Subjects:
  Adolescent Article Chickenpox Chickenpox Vaccine Female Herpesvirus 3, Human Humans Immunization Programs Male NIS-teen Surveys And Questionnaires United States Vaccination Varicella

  More +
• Source:
  J Public Health Manag Pract. 25(3):E19-E26
• Pubmed ID:
  29889179
• Pubmed Central ID:
  PMC6286230
• Document Type:
  Journal Article
• Funding:
  CC999999/ImCDC/Intramural CDC HHS/United States
• Volume:
  25
• Issue:
  3
• Collection(s):
  CDC Public Access
• Main Document Checksum:
  urn:sha256:6a5cd3b4e59c8dfbeb3bf56291fc645ecb40080971dd0be450ae6a1f40ef3a9a
• Download URL:
  https://stacks.cdc.gov/view/cdc/61241/cdc_61241_DS1.pdf
• File Type:
  [PDF - 289.01 KB ]